1	4	9	Savin	savin	NNP	_	_	B-cesDoc	B-p
2	10	14	Corp	corp	NNP	_	_	I-cesDoc	I-p
3	14	15	.	.	.	_	_	I-cesDoc	I-p
4	16	24	reported	report	VBD	_	_	I-cesDoc	I-p
5	25	26	a	a	DT	_	_	I-cesDoc	I-p
6	27	32	third	third	JJ	_	_	I-cesDoc	I-p
7	32	33	-	-	-	_	_	I-cesDoc	I-p
8	33	40	quarter	quarter	NN	_	_	I-cesDoc	I-p
9	41	44	net	net	JJ	_	_	I-cesDoc	I-p
10	45	49	loss	loss	NN	_	_	I-cesDoc	I-p
11	50	52	of	of	IN	_	_	I-cesDoc	I-p
12	53	58	$35.2	$35.2	NN	_	_	I-cesDoc	I-p
13	59	66	million	million	CD	_	_	I-cesDoc	I-p
14	66	67	,	,	,	_	_	I-cesDoc	I-p
15	68	70	or	or	CC	_	_	I-cesDoc	I-p
16	71	73	31	31	CD	_	_	I-cesDoc	I-p
17	74	79	cents	cent	NNS	_	_	I-cesDoc	I-p
18	80	81	a	a	DT	_	_	I-cesDoc	I-p
19	82	87	share	share	NN	_	_	I-cesDoc	I-p
20	87	88	,	,	,	_	_	I-cesDoc	I-p
21	89	97	compared	compare	VBN	_	_	I-cesDoc	I-p
22	98	102	with	with	IN	_	_	I-cesDoc	I-p
23	103	107	year	year	NN	_	_	I-cesDoc	I-p
24	107	108	-	-	-	_	_	I-cesDoc	I-p
25	108	115	earlier	early	JJR	_	_	I-cesDoc	I-p
26	116	122	profit	profit	NN	_	_	I-cesDoc	I-p
27	123	125	of	of	IN	_	_	I-cesDoc	I-p
28	126	130	$3.8	$3.8	NN	_	_	I-cesDoc	I-p
29	131	138	million	million	CD	_	_	I-cesDoc	I-p
30	138	139	,	,	,	_	_	I-cesDoc	I-p
31	140	142	or	or	CC	_	_	I-cesDoc	I-p
32	143	146	one	one	CD	_	_	I-cesDoc	I-p
33	147	151	cent	cent	NN	_	_	I-cesDoc	I-p
34	152	153	a	a	DT	_	_	I-cesDoc	I-p
35	154	159	share	share	NN	_	_	I-cesDoc	I-p
36	159	160	.	.	.	_	_	I-cesDoc	I-p
37	164	165	A	a	DT	_	_	I-cesDoc	B-p
38	166	175	spokesman	spokesman	NN	_	_	I-cesDoc	I-p
39	176	179	for	for	IN	_	_	I-cesDoc	I-p
40	180	183	the	the	DT	_	_	I-cesDoc	I-p
41	184	192	Stamford	stamford	NNP	_	_	I-cesDoc	I-p
42	192	193	,	,	,	_	_	I-cesDoc	I-p
43	194	199	Conn.	Conn.	NN	_	_	I-cesDoc	I-p
44	199	204	based	base	VBN	_	_	I-cesDoc	I-p
45	205	212	company	company	NN	_	_	I-cesDoc	I-p
46	213	217	said	say	VBD	_	_	I-cesDoc	I-p
47	218	228	operations	operation	NNS	_	_	I-cesDoc	I-p
48	229	232	had	have	VBD	_	_	I-cesDoc	I-p
49	233	234	a	a	DT	_	_	I-cesDoc	I-p
50	235	239	loss	loss	NN	_	_	I-cesDoc	I-p
51	240	242	of	of	IN	_	_	I-cesDoc	I-p
52	243	247	$5.5	$5.5	NN	_	_	I-cesDoc	I-p
53	248	255	million	million	CD	_	_	I-cesDoc	I-p
54	256	259	for	for	IN	_	_	I-cesDoc	I-p
55	260	263	the	the	DT	_	_	I-cesDoc	I-p
56	264	271	quarter	quarter	NN	_	_	I-cesDoc	I-p
57	271	272	;	;	:	_	_	I-cesDoc	I-p
58	273	275	in	in	IN	_	_	I-cesDoc	I-p
59	276	284	addition	addition	NN	_	_	I-cesDoc	I-p
60	284	285	,	,	,	_	_	I-cesDoc	I-p
61	286	289	the	the	DT	_	_	I-cesDoc	I-p
62	290	294	loss	loss	NN	_	_	I-cesDoc	I-p
63	295	298	was	be	VBD	_	_	I-cesDoc	I-p
64	299	308	magnified	magnify	VBN	_	_	I-cesDoc	I-p
65	309	311	by	by	IN	_	_	I-cesDoc	I-p
66	312	324	nonrecurring	nonrecur	VBG	_	_	I-cesDoc	I-p
67	325	332	charges	charge	NNS	_	_	I-cesDoc	I-p
68	333	341	totaling	total	VBG	_	_	I-cesDoc	I-p
69	342	347	$23.5	$23.5	NN	_	_	I-cesDoc	I-p
70	348	355	million	million	CD	_	_	I-cesDoc	I-p
71	356	359	and	and	CC	_	_	I-cesDoc	I-p
72	360	364	$8.2	$8.2	NN	_	_	I-cesDoc	I-p
73	365	372	million	million	CD	_	_	I-cesDoc	I-p
74	373	375	in	in	IN	_	_	I-cesDoc	I-p
75	376	381	asset	asset	NN	_	_	I-cesDoc	I-p
76	381	382	-	-	-	_	_	I-cesDoc	I-p
77	382	391	valuation	valuation	NN	_	_	I-cesDoc	I-p
78	392	403	adjustments	adjustment	NNS	_	_	I-cesDoc	I-p
79	404	408	that	that	IN	_	_	I-cesDoc	I-p
80	409	411	he	he	PRP	_	_	I-cesDoc	I-p
81	412	421	described	describe	VBD	_	_	I-cesDoc	I-p
82	422	424	as	as	IN	_	_	I-cesDoc	I-p
83	425	426	""	""	''	_	_	I-cesDoc	I-p
84	426	433	unusual	unusual	JJ	_	_	I-cesDoc	I-p
85	433	434	.	.	.	_	_	I-cesDoc	I-p
86	434	435	""	""	''	_	_	I-cesDoc	I-p
87	436	439	The	the	DT	_	_	I-cesDoc	I-p
88	440	447	charges	charge	NNS	_	_	I-cesDoc	I-p
89	448	452	were	be	VBD	_	_	I-cesDoc	I-p
90	453	459	partly	partly	RB	_	_	I-cesDoc	I-p
91	460	466	offset	offset	VBN	_	_	I-cesDoc	I-p
92	467	469	by	by	IN	_	_	I-cesDoc	I-p
93	470	471	a	a	DT	_	_	I-cesDoc	I-p
94	472	474	$2	$2	NN	_	_	I-cesDoc	I-p
95	475	482	million	million	CD	_	_	I-cesDoc	I-p
96	483	487	gain	gain	NN	_	_	I-cesDoc	I-p
97	488	490	on	on	IN	_	_	I-cesDoc	I-p
98	491	494	the	the	DT	_	_	I-cesDoc	I-p
99	495	499	sale	sale	NN	_	_	I-cesDoc	I-p
100	500	502	of	of	IN	_	_	I-cesDoc	I-p
101	503	514	investments	investment	NNS	_	_	I-cesDoc	I-p
102	515	517	of	of	IN	_	_	I-cesDoc	I-p
103	518	521	two	two	CD	_	_	I-cesDoc	I-p
104	522	527	joint	joint	JJ	_	_	I-cesDoc	I-p
105	528	536	ventures	venture	NNS	_	_	I-cesDoc	I-p
106	536	537	,	,	,	_	_	I-cesDoc	I-p
107	538	540	he	he	PRP	_	_	I-cesDoc	I-p
108	541	545	said	say	VBD	_	_	I-cesDoc	I-p
109	545	546	.	.	.	_	_	I-cesDoc	I-p
110	550	557	Revenue	revenue	NN	_	_	I-cesDoc	B-p
111	558	566	declined	decline	VBD	_	_	I-cesDoc	I-p
112	567	568	8	8	CD	_	_	I-cesDoc	I-p
113	568	569	%	%	NN	_	_	I-cesDoc	I-p
114	570	572	to	to	TO	_	_	I-cesDoc	I-p
115	573	578	$85.7	$85.7	NN	_	_	I-cesDoc	I-p
116	579	586	million	million	CD	_	_	I-cesDoc	I-p
117	586	587	,	,	,	_	_	I-cesDoc	I-p
118	588	592	from	from	IN	_	_	I-cesDoc	I-p
119	593	598	$93.3	$93.3	NN	_	_	I-cesDoc	I-p
120	599	606	million	million	CD	_	_	I-cesDoc	I-p
121	607	608	a	a	DT	_	_	I-cesDoc	I-p
122	609	613	year	year	NN	_	_	I-cesDoc	I-p
123	614	621	earlier	earlier	RBR	_	_	I-cesDoc	I-p
124	621	622	.	.	.	_	_	I-cesDoc	I-p
125	623	628	Savin	savin	NNP	_	_	I-cesDoc	I-p
126	629	634	cited	cite	VBD	_	_	I-cesDoc	I-p
127	635	636	""	""	''	_	_	I-cesDoc	I-p
128	636	637	a	a	DT	_	_	I-cesDoc	I-p
129	638	645	general	general	JJ	_	_	I-cesDoc	I-p
130	646	655	softening	softening	NN	_	_	I-cesDoc	I-p
131	656	658	in	in	IN	_	_	I-cesDoc	I-p
132	659	662	the	the	DT	_	_	I-cesDoc	I-p
133	663	669	demand	demand	NN	_	_	I-cesDoc	I-p
134	670	673	for	for	IN	_	_	I-cesDoc	I-p
135	674	680	office	office	NN	_	_	I-cesDoc	I-p
136	681	689	products	product	NNS	_	_	I-cesDoc	I-p
137	690	692	in	in	IN	_	_	I-cesDoc	I-p
138	693	696	the	the	DT	_	_	I-cesDoc	I-p
139	697	703	market	market	NN	_	_	I-cesDoc	I-p
140	704	712	segments	segment	NNS	_	_	I-cesDoc	I-p
141	713	715	in	in	IN	_	_	I-cesDoc	I-p
142	716	721	which	which	WDT	_	_	I-cesDoc	I-p
143	722	727	Savin	savin	NNP	_	_	I-cesDoc	I-p
144	728	736	competes	compete	VBZ	_	_	I-cesDoc	I-p
145	736	737	.	.	.	_	_	I-cesDoc	I-p
146	737	738	""	""	''	_	_	I-cesDoc	I-p

